New hope for pancreatic cancer: drug combo enters phase 3 trial
Disease control
Recruiting now
This study tests whether adding the experimental drug atebimetinib to standard chemotherapy helps people with metastatic pancreatic cancer live longer. About 510 adults who have not had prior treatment will receive either the new combination or standard chemo alone. The goal is t…
Phase: PHASE3 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC